|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 14,30 PLN | +0,85% |
|
-7,02% | -47,23% |
| 21/05 | Ryvu Therapeutics : perte nette de 12,6 millions de zlotys au premier trimestre | RE |
| 21/05 | Ryvu Therapeutics S.A. publie ses résultats pour le premier trimestre clos le 31 mars 2026 | CI |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0,85% | -7,02% | -36,87% | -35,00% | -47,23% | -53,11% | -77,08% | -74,91% | -31,28% | 89,05 M | |
| +1,44% | -1,25% | +12,08% | +32,32% | +7,95% | +64,25% | +114,23% | +189,60% | +6 687,72% | 55,19 Md | |
| +4,60% | +3,02% | -0,37% | +13,00% | +13,33% | +57,38% | +48,98% | -26,63% | - | 45,75 Md | |
| -1,44% | +0,39% | +0,59% | +1,81% | -4,53% | -14,68% | -17,33% | -57,21% | - | 22,98 Md | |
| -2,69% | -2,10% | -11,22% | -29,56% | -44,96% | -6,70% | +374,02% | +229,21% | +893,26% | 20,76 Md | |
| +3,22% | -0,84% | -7,00% | -8,87% | -1,97% | +27,88% | -20,46% | -76,67% | - | 16,26 Md | |
| +0,58% | +1,08% | -4,99% | -0,03% | -19,26% | +18,85% | -37,32% | -39,88% | +43,68% | 15,42 Md | |
| -1,01% | -2,30% | +4,03% | +25,78% | +18,43% | +28,59% | +174,08% | +131,64% | +577,68% | 13,05 Md | |
| +4,95% | +11,70% | +34,35% | +65,62% | +125,53% | +125,78% | +252,19% | +1 185,59% | +409,29% | 12,45 Md | |
| +3,07% | +0,14% | -4,85% | -0,43% | +6,02% | +29,05% | - | - | - | 12,37 Md | |
| +1,18% | +5,20% | -1,50% | +14,64% | -13,15% | +77,00% | +106,03% | +380,71% | - | 11,66 Md | |
| +0,96% | +9,80% | +6,07% | +45,25% | +23,24% | +434,07% | +128,74% | -4,46% | +1 291,50% | 11,52 Md | |
| +0,86% | +12,30% | +0,01% | +27,68% | +23,98% | +142,92% | +120,92% | +269,69% | +781,21% | 10,7 Md | |
| -2,27% | -1,86% | -23,14% | -11,35% | -21,38% | -33,12% | +458,94% | +108,02% | +76,96% | 10,67 Md | |
| +4,35% | -4,84% | -23,87% | -24,26% | -22,52% | -4,11% | +149,43% | +41,67% | - | 10,29 Md | |
| +0,06% | +0,15% | +20,63% | +30,24% | +22,71% | +64,57% | +181,93% | - | - | 9,75 Md | |
| +0,74% | -.--% | -.--% | -.--% | -.--% | -.--% | +31,58% | +227,46% | - | 8,19 Md | |
| +1,63% | -8,12% | -20,16% | -26,50% | -4,86% | +31,73% | +92,96% | -46,44% | - | 7,8 Md | |
| +5,29% | +3,66% | -8,57% | -13,11% | +271,72% | +156,45% | +159,15% | -45,12% | - | 7,71 Md | |
| +0,97% | +9,35% | +22,83% | +114,16% | +169,66% | +488,54% | +2 340,33% | -45,13% | -20,95% | 7,67 Md | |
| Moyenne | +1,37% | +2,91% | -2,10% | +11,07% | +25,14% | +81,77% | +241,12% | +130,40% | +1 070,91% | 15,51 Md | |
| Moyenne pondérée par Capi. | +1,52% | +2,52% | +1,19% | +13,82% | +16,26% | +69,60% | +177,22% | +128,25% | +2 697,16% |
- Bourse
- Actions
- Action RVU
- Secteur Ryvu Therapeutics S.A.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
